Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Allergy and Asthma Proceedings
|
October 28, 2020
Clinical presentation of hereditary angioedema
Veronica Azmy, Joel P Brooks, F Ida Hsu
The Journal of Allergy and Clinical Immunology
|
November 14, 2009
Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Patrick J Brennan, Tito Rodriguez Bouza, F Ida Hsu, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 7, 2020
Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review
Joel P Brooks, Cristine Radojicic, Marc A Riedl, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 20, 2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity
Joel P Brooks, Veronica Azmy, Alison Thompson, et al.
The World Allergy Organization Journal
|
February 11, 2022
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor
Douglas H Jones, Priya Bansal, Jonathan A Bernstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2006
Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation
Daniel C Kim, F Ida Hsu, Nora A Barrett, et al.
The Journal of Allergy and Clinical Immunology
|
May 27, 2008
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases
Mariana C Castells, Nichole M Tennant, David E Sloane, et al.
The Journal of Allergy and Clinical Immunology
|
June 24, 2018
Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses
Neil Romberg, Carole Le Coz, Salomé Glauzy, et al.
Advances in Therapy
|
June 12, 2025
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study
Jonathan A Bernstein, Stephen D Betschel, Paula J Busse, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Allergy and Asthma Proceedings
|
October 28, 2020
Clinical presentation of hereditary angioedema
Veronica Azmy, Joel P Brooks, F Ida Hsu
The Journal of Allergy and Clinical Immunology
|
November 14, 2009
Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Patrick J Brennan, Tito Rodriguez Bouza, F Ida Hsu, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 7, 2020
Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review
Joel P Brooks, Cristine Radojicic, Marc A Riedl, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 20, 2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity
Joel P Brooks, Veronica Azmy, Alison Thompson, et al.
The World Allergy Organization Journal
|
February 11, 2022
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor
Douglas H Jones, Priya Bansal, Jonathan A Bernstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2006
Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation
Daniel C Kim, F Ida Hsu, Nora A Barrett, et al.
The Journal of Allergy and Clinical Immunology
|
May 27, 2008
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases
Mariana C Castells, Nichole M Tennant, David E Sloane, et al.
The Journal of Allergy and Clinical Immunology
|
June 24, 2018
Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses
Neil Romberg, Carole Le Coz, Salomé Glauzy, et al.
Advances in Therapy
|
June 12, 2025
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study
Jonathan A Bernstein, Stephen D Betschel, Paula J Busse, et al.
Page
of 1